NALOX-1
Live / Applied — Statement of use — registration review complete (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 22 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98868624
- Mark type
- Stylized text
- Filed
- 22 Nov 2024
- Published for opposition
- 18 Mar 2025
- Attorney of record
- John P. Halski
Goods and services
- Class 005 — Pharmaceuticals: Carrying cases specially adapted for filled pharmaceutical dispensing devices in the nature of nasal sprayers for administering opioid reversing pharmaceuticals
Owner
- nCase Technologies LLC, Seattle, WA, US
- nCase Technologies LLC, Seattle, WA, US
Prosecution history
- 31 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Aug 2025 — USE AMENDMENT FILED
- 02 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 13 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Feb 2025 — EXAMINER'S AMENDMENT ENTERED
- 25 Feb 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Feb 2025 — EXAMINERS AMENDMENT E-MAILED
- 25 Feb 2025 — EXAMINERS AMENDMENT -WRITTEN